Brokerages Set Phreesia, Inc. (NYSE:PHR) Target Price at $16.65

Phreesia, Inc. (NYSE:PHR) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $16.6471.

PHR has been the subject of a number of recent research reports. Mizuho cut their price objective on Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th. Stephens cut their price objective on Phreesia from $32.00 to $20.00 and set an “overweight” rating for the company in a research report on Tuesday, March 31st. Piper Sandler downgraded Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price objective for the company. in a research report on Thursday, May 28th. DA Davidson restated a “buy” rating and issued a $14.00 target price on shares of Phreesia in a report on Thursday, May 28th. Finally, Truist Financial increased their target price on Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a report on Thursday, May 28th.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Analysts are still viewing Phreesia as a “Hold,” suggesting the stock’s long-term outlook is not being broadly written off by Wall Street. Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of “Hold” by Brokerages
• Neutral Sentiment: A director, Lisa Egbuonu-Davis, sold 2,546 shares in a pre-arranged Rule 10b5-1 transaction. While insider sales can attract attention, the filing indicates it was scheduled in advance rather than a discretionary move. Director stock sale disclosure
• Negative Sentiment: Phreesia is facing repeated investor alerts from law firms about a securities fraud class action, which may keep pressure on the stock until the deadline passes and more clarity emerges. Phreesia investigation alert
• Negative Sentiment: Several firms, including Rosen Law Firm, Glancy Prongay Wolke & Rotter, The Gross Law Firm, the Schall Law Firm, and DJS Law Group, are urging investors to participate in the class action before the July 13 deadline, reinforcing the legal risk narrative. Phreesia sued for securities law violations

Insider Activity

In other news, insider David Linetsky sold 8,332 shares of the stock in a transaction on Friday, April 10th. The stock was sold at an average price of $8.07, for a total value of $67,239.24. Following the completion of the sale, the insider owned 224,056 shares in the company, valued at $1,808,131.92. This represents a 3.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 6,176 shares of the stock in a transaction on Monday, April 20th. The shares were sold at an average price of $9.06, for a total value of $55,954.56. Following the completion of the sale, the general counsel owned 157,309 shares of the company’s stock, valued at $1,425,219.54. The trade was a 3.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 42,927 shares of company stock worth $368,022 over the last quarter. Corporate insiders own 5.20% of the company’s stock.

Institutional Trading of Phreesia

Hedge funds have recently modified their holdings of the business. Van ECK Associates Corp raised its holdings in shares of Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after acquiring an additional 1,102 shares in the last quarter. Rockefeller Capital Management L.P. raised its holdings in shares of Phreesia by 354.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Phreesia by 1,119.8% during the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares in the last quarter. KBC Group NV raised its holdings in shares of Phreesia by 83.4% during the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares in the last quarter. Finally, Garner Asset Management Corp purchased a new stake in shares of Phreesia during the fourth quarter worth $81,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Price Performance

Shares of NYSE:PHR opened at $9.97 on Thursday. Phreesia has a one year low of $7.77 and a one year high of $32.76. The stock has a fifty day moving average of $9.35 and a 200-day moving average of $11.99. The company has a market capitalization of $615.94 million, a PE ratio of 66.43 and a beta of 0.91. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The company had revenue of $130.94 million during the quarter, compared to the consensus estimate of $130.08 million. During the same quarter in the prior year, the firm earned ($0.07) EPS. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. As a group, equities analysts anticipate that Phreesia will post 0.35 EPS for the current fiscal year.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.